CANCER SCIENCE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2259566, encodeId=18db2259566af, content=偏重的研究方向：肿瘤;药物;基础 经验分享：3月3号投稿，改格式改了一个月，坑爹的杂志。现在等待AE指派，不知道要等多久，真想撤稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3815517295, createdName=sunzhi8912@163.com, createdTime=Tue Apr 08 10:15:53 CST 2025, time=2025-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2252868, encodeId=7dc3225286872, content=有没有朋友遇到相同的问题，这个刊投稿格式要求一直说不能超过六个小图，究竟是指每个Figure里的小图序号A-F不能超过6个，还是小图中（例如1A）中不能超过有6个小的图片呢（例如六个组的划痕）？看了他们杂志社接受的文章也没有严格按照要求啊？被打回来改几次了，崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=e1586497680, createdName=ms9000000070012011, createdTime=Thu Feb 20 21:04:06 CST 2025, time=2025-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2258130, encodeId=99ce22581305a, content=该期刊退回率偏高，如不必要，建议不要优先考虑。尤其是针对图片较多，图片内容较多，每张图片超过6张小图的，无法通过审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Mar 28 13:01:58 CST 2025, time=2025-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2255661, encodeId=ff462255661d5, content=求助一下修回的时候发的邮件一直强调补充材料要编号为Fig.S1，但是给的标准的补充材料格式supplymentary figure 1，崩溃了，退回了好几次，实在是着急，好心人救救命啊，到底要怎么改啊，我都有阅读理解障碍了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46399546247, createdName=ms3000001521504180, createdTime=Tue Mar 11 21:10:34 CST 2025, time=2025-03-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2250781, encodeId=9e092250e811c, content=偏重的研究方向：肿瘤;临床 经验分享：This associate editor read your manuscript and regrets to say that your paper is not acceptable for publication in our journal. While your research provides valuable data, the analysis is based on a limited number of samples and does not present clear conclusions. Additionally, the underlying pathological mechanisms supporting your findings have not been demonstrated. Therefore, this associate editor does not recommend this manuscript for publication in Cancer Science. We look forward to seeing the outcomes of your further research and hope you will consider submitting those results in the future., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/eaf6a670992538bfff9986e52fed6975.jpg, createdBy=10022477991, createdName=羽翼纷飞, createdTime=Thu Feb 06 21:47:37 CST 2025, time=2025-02-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2186626, encodeId=ba452186626ee, content=偏重的研究方向：免疫;肿瘤 经验分享：一审二十天就awaiting AE recommendation了下面，求求生日给个好运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c39107865, createdName=ms7000002074141417, createdTime=Fri Feb 09 00:29:19 CST 2024, time=2024-02-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=812231, encodeId=38688122313b, content=Awaiting reviewer assignment 一周多直接变成Awaiting AE Recommendation是不是要悲剧了……都没有经过awaiting reviewer scores 啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56432360119, createdName=122cccc3m26(暂无昵称), createdTime=Sun Aug 23 08:59:04 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192978, encodeId=3eaa21929e86c, content=Awaiting Reviewer Selection得多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Wed Mar 13 16:02:12 CST 2024, time=2024-03-13, status=1, ipAttribution=堪萨斯), GetPortalCommentsPageByObjectIdResponse(id=898945, encodeId=f7288989450f, content=一审一个多月，大修三个月返回，二十天后接受，其中awaiting AE recommation四天，awaiting Eic decision一周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e9730982, createdName=guoyuanliu, createdTime=Fri Nov 13 15:20:13 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111351, encodeId=55df211135124, content=审稿速度:1.0 偏重的研究方向：肿瘤;基础研究;肝癌 经验分享：效率真的很高！外审不到一个月，两个审稿人 10.28 submit 11.1 编辑打回改格式中间 awaiting AE assignment 11.8 awaiting reviewer selection awaiting reviewer assignment awaiting reviewer scores 12.3 awaiting EIC decision 12.9 major revise 1.13 主要补了qpcr修回写了八页 1.17 awaiting AE Recommendation 1.23 awaiting EIC decision 1.24 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22435506515, createdName=-.-, createdTime=Tue Jan 24 23:20:42 CST 2023, time=2023-01-24, status=1, ipAttribution=湖北省)]

2025-04-08 sunzhi8912@163.com 来自山东省

偏重的研究方向：肿瘤;药物;基础
经验分享：3月3号投稿，改格式改了一个月，坑爹的杂志。现在等待AE指派，不知道要等多久，真想撤稿。

10 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2259566, encodeId=18db2259566af, content=偏重的研究方向：肿瘤;药物;基础 经验分享：3月3号投稿，改格式改了一个月，坑爹的杂志。现在等待AE指派，不知道要等多久，真想撤稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3815517295, createdName=sunzhi8912@163.com, createdTime=Tue Apr 08 10:15:53 CST 2025, time=2025-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2252868, encodeId=7dc3225286872, content=有没有朋友遇到相同的问题，这个刊投稿格式要求一直说不能超过六个小图，究竟是指每个Figure里的小图序号A-F不能超过6个，还是小图中（例如1A）中不能超过有6个小的图片呢（例如六个组的划痕）？看了他们杂志社接受的文章也没有严格按照要求啊？被打回来改几次了，崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=e1586497680, createdName=ms9000000070012011, createdTime=Thu Feb 20 21:04:06 CST 2025, time=2025-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2258130, encodeId=99ce22581305a, content=该期刊退回率偏高，如不必要，建议不要优先考虑。尤其是针对图片较多，图片内容较多，每张图片超过6张小图的，无法通过审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Mar 28 13:01:58 CST 2025, time=2025-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2255661, encodeId=ff462255661d5, content=求助一下修回的时候发的邮件一直强调补充材料要编号为Fig.S1，但是给的标准的补充材料格式supplymentary figure 1，崩溃了，退回了好几次，实在是着急，好心人救救命啊，到底要怎么改啊，我都有阅读理解障碍了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46399546247, createdName=ms3000001521504180, createdTime=Tue Mar 11 21:10:34 CST 2025, time=2025-03-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2250781, encodeId=9e092250e811c, content=偏重的研究方向：肿瘤;临床 经验分享：This associate editor read your manuscript and regrets to say that your paper is not acceptable for publication in our journal. While your research provides valuable data, the analysis is based on a limited number of samples and does not present clear conclusions. Additionally, the underlying pathological mechanisms supporting your findings have not been demonstrated. Therefore, this associate editor does not recommend this manuscript for publication in Cancer Science. We look forward to seeing the outcomes of your further research and hope you will consider submitting those results in the future., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/eaf6a670992538bfff9986e52fed6975.jpg, createdBy=10022477991, createdName=羽翼纷飞, createdTime=Thu Feb 06 21:47:37 CST 2025, time=2025-02-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2186626, encodeId=ba452186626ee, content=偏重的研究方向：免疫;肿瘤 经验分享：一审二十天就awaiting AE recommendation了下面，求求生日给个好运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c39107865, createdName=ms7000002074141417, createdTime=Fri Feb 09 00:29:19 CST 2024, time=2024-02-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=812231, encodeId=38688122313b, content=Awaiting reviewer assignment 一周多直接变成Awaiting AE Recommendation是不是要悲剧了……都没有经过awaiting reviewer scores 啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56432360119, createdName=122cccc3m26(暂无昵称), createdTime=Sun Aug 23 08:59:04 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192978, encodeId=3eaa21929e86c, content=Awaiting Reviewer Selection得多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Wed Mar 13 16:02:12 CST 2024, time=2024-03-13, status=1, ipAttribution=堪萨斯), GetPortalCommentsPageByObjectIdResponse(id=898945, encodeId=f7288989450f, content=一审一个多月，大修三个月返回，二十天后接受，其中awaiting AE recommation四天，awaiting Eic decision一周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e9730982, createdName=guoyuanliu, createdTime=Fri Nov 13 15:20:13 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111351, encodeId=55df211135124, content=审稿速度:1.0 偏重的研究方向：肿瘤;基础研究;肝癌 经验分享：效率真的很高！外审不到一个月，两个审稿人 10.28 submit 11.1 编辑打回改格式中间 awaiting AE assignment 11.8 awaiting reviewer selection awaiting reviewer assignment awaiting reviewer scores 12.3 awaiting EIC decision 12.9 major revise 1.13 主要补了qpcr修回写了八页 1.17 awaiting AE Recommendation 1.23 awaiting EIC decision 1.24 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22435506515, createdName=-.-, createdTime=Tue Jan 24 23:20:42 CST 2023, time=2023-01-24, status=1, ipAttribution=湖北省)]

2025-02-20 ms9000000070012011 来自重庆

有没有朋友遇到相同的问题，这个刊投稿格式要求一直说不能超过六个小图，究竟是指每个Figure里的小图序号A-F不能超过6个，还是小图中（例如1A）中不能超过有6个小的图片呢（例如六个组的划痕）？看了他们杂志社接受的文章也没有严格按照要求啊？被打回来改几次了，崩溃

17 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2259566, encodeId=18db2259566af, content=偏重的研究方向：肿瘤;药物;基础 经验分享：3月3号投稿，改格式改了一个月，坑爹的杂志。现在等待AE指派，不知道要等多久，真想撤稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3815517295, createdName=sunzhi8912@163.com, createdTime=Tue Apr 08 10:15:53 CST 2025, time=2025-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2252868, encodeId=7dc3225286872, content=有没有朋友遇到相同的问题，这个刊投稿格式要求一直说不能超过六个小图，究竟是指每个Figure里的小图序号A-F不能超过6个，还是小图中（例如1A）中不能超过有6个小的图片呢（例如六个组的划痕）？看了他们杂志社接受的文章也没有严格按照要求啊？被打回来改几次了，崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=e1586497680, createdName=ms9000000070012011, createdTime=Thu Feb 20 21:04:06 CST 2025, time=2025-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2258130, encodeId=99ce22581305a, content=该期刊退回率偏高，如不必要，建议不要优先考虑。尤其是针对图片较多，图片内容较多，每张图片超过6张小图的，无法通过审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Mar 28 13:01:58 CST 2025, time=2025-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2255661, encodeId=ff462255661d5, content=求助一下修回的时候发的邮件一直强调补充材料要编号为Fig.S1，但是给的标准的补充材料格式supplymentary figure 1，崩溃了，退回了好几次，实在是着急，好心人救救命啊，到底要怎么改啊，我都有阅读理解障碍了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46399546247, createdName=ms3000001521504180, createdTime=Tue Mar 11 21:10:34 CST 2025, time=2025-03-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2250781, encodeId=9e092250e811c, content=偏重的研究方向：肿瘤;临床 经验分享：This associate editor read your manuscript and regrets to say that your paper is not acceptable for publication in our journal. While your research provides valuable data, the analysis is based on a limited number of samples and does not present clear conclusions. Additionally, the underlying pathological mechanisms supporting your findings have not been demonstrated. Therefore, this associate editor does not recommend this manuscript for publication in Cancer Science. We look forward to seeing the outcomes of your further research and hope you will consider submitting those results in the future., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/eaf6a670992538bfff9986e52fed6975.jpg, createdBy=10022477991, createdName=羽翼纷飞, createdTime=Thu Feb 06 21:47:37 CST 2025, time=2025-02-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2186626, encodeId=ba452186626ee, content=偏重的研究方向：免疫;肿瘤 经验分享：一审二十天就awaiting AE recommendation了下面，求求生日给个好运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c39107865, createdName=ms7000002074141417, createdTime=Fri Feb 09 00:29:19 CST 2024, time=2024-02-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=812231, encodeId=38688122313b, content=Awaiting reviewer assignment 一周多直接变成Awaiting AE Recommendation是不是要悲剧了……都没有经过awaiting reviewer scores 啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56432360119, createdName=122cccc3m26(暂无昵称), createdTime=Sun Aug 23 08:59:04 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192978, encodeId=3eaa21929e86c, content=Awaiting Reviewer Selection得多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Wed Mar 13 16:02:12 CST 2024, time=2024-03-13, status=1, ipAttribution=堪萨斯), GetPortalCommentsPageByObjectIdResponse(id=898945, encodeId=f7288989450f, content=一审一个多月，大修三个月返回，二十天后接受，其中awaiting AE recommation四天，awaiting Eic decision一周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e9730982, createdName=guoyuanliu, createdTime=Fri Nov 13 15:20:13 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111351, encodeId=55df211135124, content=审稿速度:1.0 偏重的研究方向：肿瘤;基础研究;肝癌 经验分享：效率真的很高！外审不到一个月，两个审稿人 10.28 submit 11.1 编辑打回改格式中间 awaiting AE assignment 11.8 awaiting reviewer selection awaiting reviewer assignment awaiting reviewer scores 12.3 awaiting EIC decision 12.9 major revise 1.13 主要补了qpcr修回写了八页 1.17 awaiting AE Recommendation 1.23 awaiting EIC decision 1.24 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22435506515, createdName=-.-, createdTime=Tue Jan 24 23:20:42 CST 2023, time=2023-01-24, status=1, ipAttribution=湖北省)]

2025-03-28 匿名用户

该期刊退回率偏高，如不必要，建议不要优先考虑。尤其是针对图片较多，图片内容较多，每张图片超过6张小图的，无法通过审稿

22 0

[GetPortalCommentsPageByObjectIdResponse(id=2259566, encodeId=18db2259566af, content=偏重的研究方向：肿瘤;药物;基础 经验分享：3月3号投稿，改格式改了一个月，坑爹的杂志。现在等待AE指派，不知道要等多久，真想撤稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3815517295, createdName=sunzhi8912@163.com, createdTime=Tue Apr 08 10:15:53 CST 2025, time=2025-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2252868, encodeId=7dc3225286872, content=有没有朋友遇到相同的问题，这个刊投稿格式要求一直说不能超过六个小图，究竟是指每个Figure里的小图序号A-F不能超过6个，还是小图中（例如1A）中不能超过有6个小的图片呢（例如六个组的划痕）？看了他们杂志社接受的文章也没有严格按照要求啊？被打回来改几次了，崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=e1586497680, createdName=ms9000000070012011, createdTime=Thu Feb 20 21:04:06 CST 2025, time=2025-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2258130, encodeId=99ce22581305a, content=该期刊退回率偏高，如不必要，建议不要优先考虑。尤其是针对图片较多，图片内容较多，每张图片超过6张小图的，无法通过审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Mar 28 13:01:58 CST 2025, time=2025-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2255661, encodeId=ff462255661d5, content=求助一下修回的时候发的邮件一直强调补充材料要编号为Fig.S1，但是给的标准的补充材料格式supplymentary figure 1，崩溃了，退回了好几次，实在是着急，好心人救救命啊，到底要怎么改啊，我都有阅读理解障碍了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46399546247, createdName=ms3000001521504180, createdTime=Tue Mar 11 21:10:34 CST 2025, time=2025-03-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2250781, encodeId=9e092250e811c, content=偏重的研究方向：肿瘤;临床 经验分享：This associate editor read your manuscript and regrets to say that your paper is not acceptable for publication in our journal. While your research provides valuable data, the analysis is based on a limited number of samples and does not present clear conclusions. Additionally, the underlying pathological mechanisms supporting your findings have not been demonstrated. Therefore, this associate editor does not recommend this manuscript for publication in Cancer Science. We look forward to seeing the outcomes of your further research and hope you will consider submitting those results in the future., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/eaf6a670992538bfff9986e52fed6975.jpg, createdBy=10022477991, createdName=羽翼纷飞, createdTime=Thu Feb 06 21:47:37 CST 2025, time=2025-02-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2186626, encodeId=ba452186626ee, content=偏重的研究方向：免疫;肿瘤 经验分享：一审二十天就awaiting AE recommendation了下面，求求生日给个好运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c39107865, createdName=ms7000002074141417, createdTime=Fri Feb 09 00:29:19 CST 2024, time=2024-02-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=812231, encodeId=38688122313b, content=Awaiting reviewer assignment 一周多直接变成Awaiting AE Recommendation是不是要悲剧了……都没有经过awaiting reviewer scores 啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56432360119, createdName=122cccc3m26(暂无昵称), createdTime=Sun Aug 23 08:59:04 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192978, encodeId=3eaa21929e86c, content=Awaiting Reviewer Selection得多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Wed Mar 13 16:02:12 CST 2024, time=2024-03-13, status=1, ipAttribution=堪萨斯), GetPortalCommentsPageByObjectIdResponse(id=898945, encodeId=f7288989450f, content=一审一个多月，大修三个月返回，二十天后接受，其中awaiting AE recommation四天，awaiting Eic decision一周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e9730982, createdName=guoyuanliu, createdTime=Fri Nov 13 15:20:13 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111351, encodeId=55df211135124, content=审稿速度:1.0 偏重的研究方向：肿瘤;基础研究;肝癌 经验分享：效率真的很高！外审不到一个月，两个审稿人 10.28 submit 11.1 编辑打回改格式中间 awaiting AE assignment 11.8 awaiting reviewer selection awaiting reviewer assignment awaiting reviewer scores 12.3 awaiting EIC decision 12.9 major revise 1.13 主要补了qpcr修回写了八页 1.17 awaiting AE Recommendation 1.23 awaiting EIC decision 1.24 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22435506515, createdName=-.-, createdTime=Tue Jan 24 23:20:42 CST 2023, time=2023-01-24, status=1, ipAttribution=湖北省)]

2025-03-11 ms3000001521504180 来自安徽省

求助一下修回的时候发的邮件一直强调补充材料要编号为Fig.S1，但是给的标准的补充材料格式supplymentary figure 1，崩溃了，退回了好几次，实在是着急，好心人救救命啊，到底要怎么改啊，我都有阅读理解障碍了。

11 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2259566, encodeId=18db2259566af, content=偏重的研究方向：肿瘤;药物;基础 经验分享：3月3号投稿，改格式改了一个月，坑爹的杂志。现在等待AE指派，不知道要等多久，真想撤稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3815517295, createdName=sunzhi8912@163.com, createdTime=Tue Apr 08 10:15:53 CST 2025, time=2025-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2252868, encodeId=7dc3225286872, content=有没有朋友遇到相同的问题，这个刊投稿格式要求一直说不能超过六个小图，究竟是指每个Figure里的小图序号A-F不能超过6个，还是小图中（例如1A）中不能超过有6个小的图片呢（例如六个组的划痕）？看了他们杂志社接受的文章也没有严格按照要求啊？被打回来改几次了，崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=e1586497680, createdName=ms9000000070012011, createdTime=Thu Feb 20 21:04:06 CST 2025, time=2025-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2258130, encodeId=99ce22581305a, content=该期刊退回率偏高，如不必要，建议不要优先考虑。尤其是针对图片较多，图片内容较多，每张图片超过6张小图的，无法通过审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Mar 28 13:01:58 CST 2025, time=2025-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2255661, encodeId=ff462255661d5, content=求助一下修回的时候发的邮件一直强调补充材料要编号为Fig.S1，但是给的标准的补充材料格式supplymentary figure 1，崩溃了，退回了好几次，实在是着急，好心人救救命啊，到底要怎么改啊，我都有阅读理解障碍了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46399546247, createdName=ms3000001521504180, createdTime=Tue Mar 11 21:10:34 CST 2025, time=2025-03-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2250781, encodeId=9e092250e811c, content=偏重的研究方向：肿瘤;临床 经验分享：This associate editor read your manuscript and regrets to say that your paper is not acceptable for publication in our journal. While your research provides valuable data, the analysis is based on a limited number of samples and does not present clear conclusions. Additionally, the underlying pathological mechanisms supporting your findings have not been demonstrated. Therefore, this associate editor does not recommend this manuscript for publication in Cancer Science. We look forward to seeing the outcomes of your further research and hope you will consider submitting those results in the future., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/eaf6a670992538bfff9986e52fed6975.jpg, createdBy=10022477991, createdName=羽翼纷飞, createdTime=Thu Feb 06 21:47:37 CST 2025, time=2025-02-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2186626, encodeId=ba452186626ee, content=偏重的研究方向：免疫;肿瘤 经验分享：一审二十天就awaiting AE recommendation了下面，求求生日给个好运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c39107865, createdName=ms7000002074141417, createdTime=Fri Feb 09 00:29:19 CST 2024, time=2024-02-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=812231, encodeId=38688122313b, content=Awaiting reviewer assignment 一周多直接变成Awaiting AE Recommendation是不是要悲剧了……都没有经过awaiting reviewer scores 啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56432360119, createdName=122cccc3m26(暂无昵称), createdTime=Sun Aug 23 08:59:04 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192978, encodeId=3eaa21929e86c, content=Awaiting Reviewer Selection得多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Wed Mar 13 16:02:12 CST 2024, time=2024-03-13, status=1, ipAttribution=堪萨斯), GetPortalCommentsPageByObjectIdResponse(id=898945, encodeId=f7288989450f, content=一审一个多月，大修三个月返回，二十天后接受，其中awaiting AE recommation四天，awaiting Eic decision一周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e9730982, createdName=guoyuanliu, createdTime=Fri Nov 13 15:20:13 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111351, encodeId=55df211135124, content=审稿速度:1.0 偏重的研究方向：肿瘤;基础研究;肝癌 经验分享：效率真的很高！外审不到一个月，两个审稿人 10.28 submit 11.1 编辑打回改格式中间 awaiting AE assignment 11.8 awaiting reviewer selection awaiting reviewer assignment awaiting reviewer scores 12.3 awaiting EIC decision 12.9 major revise 1.13 主要补了qpcr修回写了八页 1.17 awaiting AE Recommendation 1.23 awaiting EIC decision 1.24 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22435506515, createdName=-.-, createdTime=Tue Jan 24 23:20:42 CST 2023, time=2023-01-24, status=1, ipAttribution=湖北省)]

2025-02-06 羽翼纷飞来自重庆

偏重的研究方向：肿瘤;临床
经验分享：This associate editor read your manuscript and regrets to say that your paper is not acceptable for publication in our journal. While your research provides valuable data, the analysis is based on a limited number of samples and does not present clear conclusions. Additionally, the underlying pathological mechanisms supporting your findings have not been demonstrated. Therefore, this associate editor does not recommend this manuscript for publication in Cancer Science. We look forward to seeing the outcomes of your further research and hope you will consider submitting those results in the future.

16 0

[GetPortalCommentsPageByObjectIdResponse(id=2259566, encodeId=18db2259566af, content=偏重的研究方向：肿瘤;药物;基础 经验分享：3月3号投稿，改格式改了一个月，坑爹的杂志。现在等待AE指派，不知道要等多久，真想撤稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3815517295, createdName=sunzhi8912@163.com, createdTime=Tue Apr 08 10:15:53 CST 2025, time=2025-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2252868, encodeId=7dc3225286872, content=有没有朋友遇到相同的问题，这个刊投稿格式要求一直说不能超过六个小图，究竟是指每个Figure里的小图序号A-F不能超过6个，还是小图中（例如1A）中不能超过有6个小的图片呢（例如六个组的划痕）？看了他们杂志社接受的文章也没有严格按照要求啊？被打回来改几次了，崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=e1586497680, createdName=ms9000000070012011, createdTime=Thu Feb 20 21:04:06 CST 2025, time=2025-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2258130, encodeId=99ce22581305a, content=该期刊退回率偏高，如不必要，建议不要优先考虑。尤其是针对图片较多，图片内容较多，每张图片超过6张小图的，无法通过审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Mar 28 13:01:58 CST 2025, time=2025-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2255661, encodeId=ff462255661d5, content=求助一下修回的时候发的邮件一直强调补充材料要编号为Fig.S1，但是给的标准的补充材料格式supplymentary figure 1，崩溃了，退回了好几次，实在是着急，好心人救救命啊，到底要怎么改啊，我都有阅读理解障碍了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46399546247, createdName=ms3000001521504180, createdTime=Tue Mar 11 21:10:34 CST 2025, time=2025-03-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2250781, encodeId=9e092250e811c, content=偏重的研究方向：肿瘤;临床 经验分享：This associate editor read your manuscript and regrets to say that your paper is not acceptable for publication in our journal. While your research provides valuable data, the analysis is based on a limited number of samples and does not present clear conclusions. Additionally, the underlying pathological mechanisms supporting your findings have not been demonstrated. Therefore, this associate editor does not recommend this manuscript for publication in Cancer Science. We look forward to seeing the outcomes of your further research and hope you will consider submitting those results in the future., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/eaf6a670992538bfff9986e52fed6975.jpg, createdBy=10022477991, createdName=羽翼纷飞, createdTime=Thu Feb 06 21:47:37 CST 2025, time=2025-02-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2186626, encodeId=ba452186626ee, content=偏重的研究方向：免疫;肿瘤 经验分享：一审二十天就awaiting AE recommendation了下面，求求生日给个好运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c39107865, createdName=ms7000002074141417, createdTime=Fri Feb 09 00:29:19 CST 2024, time=2024-02-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=812231, encodeId=38688122313b, content=Awaiting reviewer assignment 一周多直接变成Awaiting AE Recommendation是不是要悲剧了……都没有经过awaiting reviewer scores 啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56432360119, createdName=122cccc3m26(暂无昵称), createdTime=Sun Aug 23 08:59:04 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192978, encodeId=3eaa21929e86c, content=Awaiting Reviewer Selection得多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Wed Mar 13 16:02:12 CST 2024, time=2024-03-13, status=1, ipAttribution=堪萨斯), GetPortalCommentsPageByObjectIdResponse(id=898945, encodeId=f7288989450f, content=一审一个多月，大修三个月返回，二十天后接受，其中awaiting AE recommation四天，awaiting Eic decision一周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e9730982, createdName=guoyuanliu, createdTime=Fri Nov 13 15:20:13 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111351, encodeId=55df211135124, content=审稿速度:1.0 偏重的研究方向：肿瘤;基础研究;肝癌 经验分享：效率真的很高！外审不到一个月，两个审稿人 10.28 submit 11.1 编辑打回改格式中间 awaiting AE assignment 11.8 awaiting reviewer selection awaiting reviewer assignment awaiting reviewer scores 12.3 awaiting EIC decision 12.9 major revise 1.13 主要补了qpcr修回写了八页 1.17 awaiting AE Recommendation 1.23 awaiting EIC decision 1.24 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22435506515, createdName=-.-, createdTime=Tue Jan 24 23:20:42 CST 2023, time=2023-01-24, status=1, ipAttribution=湖北省)]

2024-02-09 ms7000002074141417 来自浙江省

偏重的研究方向：免疫;肿瘤
经验分享：一审二十天就awaiting AE recommendation了下面，求求生日给个好运吧

83 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2259566, encodeId=18db2259566af, content=偏重的研究方向：肿瘤;药物;基础 经验分享：3月3号投稿，改格式改了一个月，坑爹的杂志。现在等待AE指派，不知道要等多久，真想撤稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3815517295, createdName=sunzhi8912@163.com, createdTime=Tue Apr 08 10:15:53 CST 2025, time=2025-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2252868, encodeId=7dc3225286872, content=有没有朋友遇到相同的问题，这个刊投稿格式要求一直说不能超过六个小图，究竟是指每个Figure里的小图序号A-F不能超过6个，还是小图中（例如1A）中不能超过有6个小的图片呢（例如六个组的划痕）？看了他们杂志社接受的文章也没有严格按照要求啊？被打回来改几次了，崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=e1586497680, createdName=ms9000000070012011, createdTime=Thu Feb 20 21:04:06 CST 2025, time=2025-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2258130, encodeId=99ce22581305a, content=该期刊退回率偏高，如不必要，建议不要优先考虑。尤其是针对图片较多，图片内容较多，每张图片超过6张小图的，无法通过审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Mar 28 13:01:58 CST 2025, time=2025-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2255661, encodeId=ff462255661d5, content=求助一下修回的时候发的邮件一直强调补充材料要编号为Fig.S1，但是给的标准的补充材料格式supplymentary figure 1，崩溃了，退回了好几次，实在是着急，好心人救救命啊，到底要怎么改啊，我都有阅读理解障碍了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46399546247, createdName=ms3000001521504180, createdTime=Tue Mar 11 21:10:34 CST 2025, time=2025-03-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2250781, encodeId=9e092250e811c, content=偏重的研究方向：肿瘤;临床 经验分享：This associate editor read your manuscript and regrets to say that your paper is not acceptable for publication in our journal. While your research provides valuable data, the analysis is based on a limited number of samples and does not present clear conclusions. Additionally, the underlying pathological mechanisms supporting your findings have not been demonstrated. Therefore, this associate editor does not recommend this manuscript for publication in Cancer Science. We look forward to seeing the outcomes of your further research and hope you will consider submitting those results in the future., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/eaf6a670992538bfff9986e52fed6975.jpg, createdBy=10022477991, createdName=羽翼纷飞, createdTime=Thu Feb 06 21:47:37 CST 2025, time=2025-02-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2186626, encodeId=ba452186626ee, content=偏重的研究方向：免疫;肿瘤 经验分享：一审二十天就awaiting AE recommendation了下面，求求生日给个好运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c39107865, createdName=ms7000002074141417, createdTime=Fri Feb 09 00:29:19 CST 2024, time=2024-02-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=812231, encodeId=38688122313b, content=Awaiting reviewer assignment 一周多直接变成Awaiting AE Recommendation是不是要悲剧了……都没有经过awaiting reviewer scores 啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56432360119, createdName=122cccc3m26(暂无昵称), createdTime=Sun Aug 23 08:59:04 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192978, encodeId=3eaa21929e86c, content=Awaiting Reviewer Selection得多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Wed Mar 13 16:02:12 CST 2024, time=2024-03-13, status=1, ipAttribution=堪萨斯), GetPortalCommentsPageByObjectIdResponse(id=898945, encodeId=f7288989450f, content=一审一个多月，大修三个月返回，二十天后接受，其中awaiting AE recommation四天，awaiting Eic decision一周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e9730982, createdName=guoyuanliu, createdTime=Fri Nov 13 15:20:13 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111351, encodeId=55df211135124, content=审稿速度:1.0 偏重的研究方向：肿瘤;基础研究;肝癌 经验分享：效率真的很高！外审不到一个月，两个审稿人 10.28 submit 11.1 编辑打回改格式中间 awaiting AE assignment 11.8 awaiting reviewer selection awaiting reviewer assignment awaiting reviewer scores 12.3 awaiting EIC decision 12.9 major revise 1.13 主要补了qpcr修回写了八页 1.17 awaiting AE Recommendation 1.23 awaiting EIC decision 1.24 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22435506515, createdName=-.-, createdTime=Tue Jan 24 23:20:42 CST 2023, time=2023-01-24, status=1, ipAttribution=湖北省)]

2020-08-23 122cccc3m26(暂无昵称)

Awaiting reviewer assignment 一周多直接变成Awaiting AE Recommendation是不是要悲剧了……都没有经过awaiting reviewer scores 啊……

151 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2259566, encodeId=18db2259566af, content=偏重的研究方向：肿瘤;药物;基础 经验分享：3月3号投稿，改格式改了一个月，坑爹的杂志。现在等待AE指派，不知道要等多久，真想撤稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3815517295, createdName=sunzhi8912@163.com, createdTime=Tue Apr 08 10:15:53 CST 2025, time=2025-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2252868, encodeId=7dc3225286872, content=有没有朋友遇到相同的问题，这个刊投稿格式要求一直说不能超过六个小图，究竟是指每个Figure里的小图序号A-F不能超过6个，还是小图中（例如1A）中不能超过有6个小的图片呢（例如六个组的划痕）？看了他们杂志社接受的文章也没有严格按照要求啊？被打回来改几次了，崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=e1586497680, createdName=ms9000000070012011, createdTime=Thu Feb 20 21:04:06 CST 2025, time=2025-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2258130, encodeId=99ce22581305a, content=该期刊退回率偏高，如不必要，建议不要优先考虑。尤其是针对图片较多，图片内容较多，每张图片超过6张小图的，无法通过审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Mar 28 13:01:58 CST 2025, time=2025-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2255661, encodeId=ff462255661d5, content=求助一下修回的时候发的邮件一直强调补充材料要编号为Fig.S1，但是给的标准的补充材料格式supplymentary figure 1，崩溃了，退回了好几次，实在是着急，好心人救救命啊，到底要怎么改啊，我都有阅读理解障碍了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46399546247, createdName=ms3000001521504180, createdTime=Tue Mar 11 21:10:34 CST 2025, time=2025-03-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2250781, encodeId=9e092250e811c, content=偏重的研究方向：肿瘤;临床 经验分享：This associate editor read your manuscript and regrets to say that your paper is not acceptable for publication in our journal. While your research provides valuable data, the analysis is based on a limited number of samples and does not present clear conclusions. Additionally, the underlying pathological mechanisms supporting your findings have not been demonstrated. Therefore, this associate editor does not recommend this manuscript for publication in Cancer Science. We look forward to seeing the outcomes of your further research and hope you will consider submitting those results in the future., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/eaf6a670992538bfff9986e52fed6975.jpg, createdBy=10022477991, createdName=羽翼纷飞, createdTime=Thu Feb 06 21:47:37 CST 2025, time=2025-02-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2186626, encodeId=ba452186626ee, content=偏重的研究方向：免疫;肿瘤 经验分享：一审二十天就awaiting AE recommendation了下面，求求生日给个好运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c39107865, createdName=ms7000002074141417, createdTime=Fri Feb 09 00:29:19 CST 2024, time=2024-02-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=812231, encodeId=38688122313b, content=Awaiting reviewer assignment 一周多直接变成Awaiting AE Recommendation是不是要悲剧了……都没有经过awaiting reviewer scores 啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56432360119, createdName=122cccc3m26(暂无昵称), createdTime=Sun Aug 23 08:59:04 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192978, encodeId=3eaa21929e86c, content=Awaiting Reviewer Selection得多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Wed Mar 13 16:02:12 CST 2024, time=2024-03-13, status=1, ipAttribution=堪萨斯), GetPortalCommentsPageByObjectIdResponse(id=898945, encodeId=f7288989450f, content=一审一个多月，大修三个月返回，二十天后接受，其中awaiting AE recommation四天，awaiting Eic decision一周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e9730982, createdName=guoyuanliu, createdTime=Fri Nov 13 15:20:13 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111351, encodeId=55df211135124, content=审稿速度:1.0 偏重的研究方向：肿瘤;基础研究;肝癌 经验分享：效率真的很高！外审不到一个月，两个审稿人 10.28 submit 11.1 编辑打回改格式中间 awaiting AE assignment 11.8 awaiting reviewer selection awaiting reviewer assignment awaiting reviewer scores 12.3 awaiting EIC decision 12.9 major revise 1.13 主要补了qpcr修回写了八页 1.17 awaiting AE Recommendation 1.23 awaiting EIC decision 1.24 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22435506515, createdName=-.-, createdTime=Tue Jan 24 23:20:42 CST 2023, time=2023-01-24, status=1, ipAttribution=湖北省)]

2024-03-13 好运好运来自堪萨斯

Awaiting Reviewer Selection得多久呀

57 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2259566, encodeId=18db2259566af, content=偏重的研究方向：肿瘤;药物;基础 经验分享：3月3号投稿，改格式改了一个月，坑爹的杂志。现在等待AE指派，不知道要等多久，真想撤稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3815517295, createdName=sunzhi8912@163.com, createdTime=Tue Apr 08 10:15:53 CST 2025, time=2025-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2252868, encodeId=7dc3225286872, content=有没有朋友遇到相同的问题，这个刊投稿格式要求一直说不能超过六个小图，究竟是指每个Figure里的小图序号A-F不能超过6个，还是小图中（例如1A）中不能超过有6个小的图片呢（例如六个组的划痕）？看了他们杂志社接受的文章也没有严格按照要求啊？被打回来改几次了，崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=e1586497680, createdName=ms9000000070012011, createdTime=Thu Feb 20 21:04:06 CST 2025, time=2025-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2258130, encodeId=99ce22581305a, content=该期刊退回率偏高，如不必要，建议不要优先考虑。尤其是针对图片较多，图片内容较多，每张图片超过6张小图的，无法通过审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Mar 28 13:01:58 CST 2025, time=2025-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2255661, encodeId=ff462255661d5, content=求助一下修回的时候发的邮件一直强调补充材料要编号为Fig.S1，但是给的标准的补充材料格式supplymentary figure 1，崩溃了，退回了好几次，实在是着急，好心人救救命啊，到底要怎么改啊，我都有阅读理解障碍了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46399546247, createdName=ms3000001521504180, createdTime=Tue Mar 11 21:10:34 CST 2025, time=2025-03-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2250781, encodeId=9e092250e811c, content=偏重的研究方向：肿瘤;临床 经验分享：This associate editor read your manuscript and regrets to say that your paper is not acceptable for publication in our journal. While your research provides valuable data, the analysis is based on a limited number of samples and does not present clear conclusions. Additionally, the underlying pathological mechanisms supporting your findings have not been demonstrated. Therefore, this associate editor does not recommend this manuscript for publication in Cancer Science. We look forward to seeing the outcomes of your further research and hope you will consider submitting those results in the future., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/eaf6a670992538bfff9986e52fed6975.jpg, createdBy=10022477991, createdName=羽翼纷飞, createdTime=Thu Feb 06 21:47:37 CST 2025, time=2025-02-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2186626, encodeId=ba452186626ee, content=偏重的研究方向：免疫;肿瘤 经验分享：一审二十天就awaiting AE recommendation了下面，求求生日给个好运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c39107865, createdName=ms7000002074141417, createdTime=Fri Feb 09 00:29:19 CST 2024, time=2024-02-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=812231, encodeId=38688122313b, content=Awaiting reviewer assignment 一周多直接变成Awaiting AE Recommendation是不是要悲剧了……都没有经过awaiting reviewer scores 啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56432360119, createdName=122cccc3m26(暂无昵称), createdTime=Sun Aug 23 08:59:04 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192978, encodeId=3eaa21929e86c, content=Awaiting Reviewer Selection得多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Wed Mar 13 16:02:12 CST 2024, time=2024-03-13, status=1, ipAttribution=堪萨斯), GetPortalCommentsPageByObjectIdResponse(id=898945, encodeId=f7288989450f, content=一审一个多月，大修三个月返回，二十天后接受，其中awaiting AE recommation四天，awaiting Eic decision一周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e9730982, createdName=guoyuanliu, createdTime=Fri Nov 13 15:20:13 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111351, encodeId=55df211135124, content=审稿速度:1.0 偏重的研究方向：肿瘤;基础研究;肝癌 经验分享：效率真的很高！外审不到一个月，两个审稿人 10.28 submit 11.1 编辑打回改格式中间 awaiting AE assignment 11.8 awaiting reviewer selection awaiting reviewer assignment awaiting reviewer scores 12.3 awaiting EIC decision 12.9 major revise 1.13 主要补了qpcr修回写了八页 1.17 awaiting AE Recommendation 1.23 awaiting EIC decision 1.24 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22435506515, createdName=-.-, createdTime=Tue Jan 24 23:20:42 CST 2023, time=2023-01-24, status=1, ipAttribution=湖北省)]

2020-11-13 guoyuanliu

一审一个多月，大修三个月返回，二十天后接受，其中awaiting AE recommation四天，awaiting Eic decision一周。

173 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2259566, encodeId=18db2259566af, content=偏重的研究方向：肿瘤;药物;基础 经验分享：3月3号投稿，改格式改了一个月，坑爹的杂志。现在等待AE指派，不知道要等多久，真想撤稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3815517295, createdName=sunzhi8912@163.com, createdTime=Tue Apr 08 10:15:53 CST 2025, time=2025-04-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2252868, encodeId=7dc3225286872, content=有没有朋友遇到相同的问题，这个刊投稿格式要求一直说不能超过六个小图，究竟是指每个Figure里的小图序号A-F不能超过6个，还是小图中（例如1A）中不能超过有6个小的图片呢（例如六个组的划痕）？看了他们杂志社接受的文章也没有严格按照要求啊？被打回来改几次了，崩溃, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=e1586497680, createdName=ms9000000070012011, createdTime=Thu Feb 20 21:04:06 CST 2025, time=2025-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2258130, encodeId=99ce22581305a, content=该期刊退回率偏高，如不必要，建议不要优先考虑。尤其是针对图片较多，图片内容较多，每张图片超过6张小图的，无法通过审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Mar 28 13:01:58 CST 2025, time=2025-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2255661, encodeId=ff462255661d5, content=求助一下修回的时候发的邮件一直强调补充材料要编号为Fig.S1，但是给的标准的补充材料格式supplymentary figure 1，崩溃了，退回了好几次，实在是着急，好心人救救命啊，到底要怎么改啊，我都有阅读理解障碍了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46399546247, createdName=ms3000001521504180, createdTime=Tue Mar 11 21:10:34 CST 2025, time=2025-03-11, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2250781, encodeId=9e092250e811c, content=偏重的研究方向：肿瘤;临床 经验分享：This associate editor read your manuscript and regrets to say that your paper is not acceptable for publication in our journal. While your research provides valuable data, the analysis is based on a limited number of samples and does not present clear conclusions. Additionally, the underlying pathological mechanisms supporting your findings have not been demonstrated. Therefore, this associate editor does not recommend this manuscript for publication in Cancer Science. We look forward to seeing the outcomes of your further research and hope you will consider submitting those results in the future., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/eaf6a670992538bfff9986e52fed6975.jpg, createdBy=10022477991, createdName=羽翼纷飞, createdTime=Thu Feb 06 21:47:37 CST 2025, time=2025-02-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2186626, encodeId=ba452186626ee, content=偏重的研究方向：免疫;肿瘤 经验分享：一审二十天就awaiting AE recommendation了下面，求求生日给个好运吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c39107865, createdName=ms7000002074141417, createdTime=Fri Feb 09 00:29:19 CST 2024, time=2024-02-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=812231, encodeId=38688122313b, content=Awaiting reviewer assignment 一周多直接变成Awaiting AE Recommendation是不是要悲剧了……都没有经过awaiting reviewer scores 啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56432360119, createdName=122cccc3m26(暂无昵称), createdTime=Sun Aug 23 08:59:04 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192978, encodeId=3eaa21929e86c, content=Awaiting Reviewer Selection得多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=374a8247111, createdName=好运好运, createdTime=Wed Mar 13 16:02:12 CST 2024, time=2024-03-13, status=1, ipAttribution=堪萨斯), GetPortalCommentsPageByObjectIdResponse(id=898945, encodeId=f7288989450f, content=一审一个多月，大修三个月返回，二十天后接受，其中awaiting AE recommation四天，awaiting Eic decision一周。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e9730982, createdName=guoyuanliu, createdTime=Fri Nov 13 15:20:13 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111351, encodeId=55df211135124, content=审稿速度:1.0 偏重的研究方向：肿瘤;基础研究;肝癌 经验分享：效率真的很高！外审不到一个月，两个审稿人 10.28 submit 11.1 编辑打回改格式中间 awaiting AE assignment 11.8 awaiting reviewer selection awaiting reviewer assignment awaiting reviewer scores 12.3 awaiting EIC decision 12.9 major revise 1.13 主要补了qpcr修回写了八页 1.17 awaiting AE Recommendation 1.23 awaiting EIC decision 1.24 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22435506515, createdName=-.-, createdTime=Tue Jan 24 23:20:42 CST 2023, time=2023-01-24, status=1, ipAttribution=湖北省)]

2023-01-24 -.- 来自湖北省

审稿速度:1.0
偏重的研究方向：肿瘤;基础研究;肝癌
经验分享：效率真的很高！外审不到一个月，两个审稿人 10.28 submit 11.1 编辑打回改格式中间 awaiting AE assignment 11.8 awaiting reviewer selection awaiting reviewer assignment awaiting reviewer scores 12.3 awaiting EIC decision 12.9 major revise 1.13 主要补了qpcr修回写了八页 1.17 awaiting AE Recommendation 1.23 awaiting EIC decision 1.24 accept

182 11

展开11条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务